ATE444073T1 - Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten - Google Patents

Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Info

Publication number
ATE444073T1
ATE444073T1 AT98923673T AT98923673T ATE444073T1 AT E444073 T1 ATE444073 T1 AT E444073T1 AT 98923673 T AT98923673 T AT 98923673T AT 98923673 T AT98923673 T AT 98923673T AT E444073 T1 ATE444073 T1 AT E444073T1
Authority
AT
Austria
Prior art keywords
oxalate
degrading
preventing
related diseases
bacteria
Prior art date
Application number
AT98923673T
Other languages
English (en)
Inventor
Milton Allison
Harmeet Sidhu
Original Assignee
Oxthera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Inc filed Critical Oxthera Inc
Application granted granted Critical
Publication of ATE444073T1 publication Critical patent/ATE444073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT98923673T 1997-05-23 1998-05-22 Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten ATE444073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4747397P 1997-05-23 1997-05-23
PCT/US1998/010495 WO1998052586A1 (en) 1997-05-23 1998-05-22 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease

Publications (1)

Publication Number Publication Date
ATE444073T1 true ATE444073T1 (de) 2009-10-15

Family

ID=21949193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923673T ATE444073T1 (de) 1997-05-23 1998-05-22 Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten

Country Status (12)

Country Link
US (1) US6200562B1 (de)
EP (2) EP0983076B1 (de)
JP (2) JP4996780B2 (de)
KR (1) KR20010012845A (de)
AT (1) ATE444073T1 (de)
AU (1) AU7590798A (de)
CA (1) CA2288709C (de)
CY (1) CY1109695T1 (de)
DE (1) DE69841200D1 (de)
ES (1) ES2334409T3 (de)
PT (1) PT983076E (de)
WO (1) WO1998052586A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355242B1 (en) * 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US20040120941A1 (en) * 1997-05-23 2004-06-24 Allison Milton J. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
JP4515030B2 (ja) 2001-04-23 2010-07-28 アノーメッド インコーポレイティド 腎臓結石疾患の予防のための希土類化合物の使用
JP2005537037A (ja) * 2001-10-05 2005-12-08 イクシオン・バイオテクノロジー・インコーポレーテッド 流体の蓚酸塩濃度を減少させる物質および方法
US6929940B1 (en) 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
EP1755655A4 (de) * 2004-05-07 2011-03-30 Oxthera Inc Verfahren und zusammensetzungen zum reduzieren von oxalatkonzentrationen
WO2006047680A2 (en) * 2004-10-27 2006-05-04 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
CA2610159C (en) 2005-06-10 2015-03-31 Altus Pharmaceuticals Inc. Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
SI1962873T1 (sl) * 2005-12-14 2013-10-30 Oxthera Intellectual Property Ab Farmacevtski sestavki, ki vsebujejo bakterijo za zmanjšanje oksalata
EP2366402A1 (de) 2005-12-16 2011-09-21 OxThera, Inc., Zusammensetzungen und Verfahren zur Oxalatreduktion
US8431122B2 (en) 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
CN102725403A (zh) 2009-11-25 2012-10-10 凯普托杰姆有限责任公司 草酸相关疾病治疗方法和组合物
WO2015002588A1 (en) 2013-07-05 2015-01-08 Oxthera Intellectual Property Ab Secretagogues derived from oxalobacter formigenes
JP6370309B2 (ja) 2013-12-03 2018-08-08 協和化学工業株式会社 磁性ハイドロタルサイト類複合体およびその製造方法
EP3277099B9 (de) 2015-04-02 2024-05-29 Oxidien Pharmaceuticals, Llc Hocheffiziente oxalatabbauende enzyme zum abbau von unlöslichem und löslichem oxalat
ES2913398T3 (es) 2016-06-13 2022-06-02 Oxthera Intellectual Property Ab Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato
US10927402B2 (en) * 2018-04-10 2021-02-23 Stem Arts Projects, Llc Capsule for lyophilized reagent storage and delivery
US12016899B2 (en) 2018-07-18 2024-06-25 The University Of Chicago Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
JP2022512380A (ja) 2018-12-10 2022-02-03 ノヴォム バイオテクノロジーズ，インコーポレイテッド 高シュウ酸尿症を治療するための方法及び組成物
US20240043791A1 (en) * 2020-12-23 2024-02-08 Massachusetts Institute Of Technology Modified bacterium for oxalate degradation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4747397A (en) 1986-06-12 1988-05-31 Magovern George J Flexible pad for direct myocardial tissue massage having thumb loop
US5286495A (en) 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
BR9307548A (pt) * 1992-11-30 1999-06-01 Zeneca Ltd Fragmento de dna isolado molécula recombinante célula de planta transformada oxalato decarboxilase composição processo para proteger uma planta de ácido oxálico e planta
AU7470494A (en) * 1994-05-18 1995-12-05 Human Genome Sciences, Inc. Human oxalyl-coa decarboxylase
US6090628A (en) 1994-06-20 2000-07-18 University Of Florida Materials and methods for detection of Oxalobactor formigenes
US5604111A (en) * 1994-06-20 1997-02-18 University Of Florida Research Foundation Method and kit for detection of oxalate

Also Published As

Publication number Publication date
AU7590798A (en) 1998-12-11
EP2033651A1 (de) 2009-03-11
JP2001526690A (ja) 2001-12-18
JP4996780B2 (ja) 2012-08-08
ES2334409T3 (es) 2010-03-09
CA2288709A1 (en) 1998-11-26
DE69841200D1 (de) 2009-11-12
US6200562B1 (en) 2001-03-13
KR20010012845A (ko) 2001-02-26
JP2011063597A (ja) 2011-03-31
PT983076E (pt) 2010-01-05
EP0983076A1 (de) 2000-03-08
WO1998052586A1 (en) 1998-11-26
CA2288709C (en) 2010-05-18
CY1109695T1 (el) 2014-08-13
EP0983076B1 (de) 2009-09-30

Similar Documents

Publication Publication Date Title
CY1109695T1 (el) Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
IL112667A0 (en) 6-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
BRPI0015533B8 (pt) enzima alfa-l-iduronidase humana recombinante, composição farmacêutica compreendendo a mesma e método para sua purificação
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MY124714A (en) Enzyme treatment
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
DE69905368D1 (en) Oxydiertes thymosin beta 4
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
FI920206A0 (fi) Medicinsk anvaendning, medicinskt foerfarande och preparat.
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
MXPA02000680A (es) Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
WO2002094199A3 (en) METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
EP1083927A4 (de) Menschliches "minor vault" protein p193
SE9700244D0 (sv) Novel antibacterial protein
IL112668A0 (en) 4-amino 6-substituted mycophenolic acid and derivatives thereof, their preparation and pharmaceutical compositions containing them
IL112666A0 (en) 4-amino derivatives of 5-substituted mycophenolic acid, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983076

Country of ref document: EP